Because of its small molecular size and resistance to degradation, NGAL is readily excreted and detected in the urine
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
abstract:
Can NGAL be employed as prognostic and diagnostic biomarker in human cancers? A systematic review of current evidence
BACKGROUND:
Some
studies have reported differentially altered neutrophil
gelatinase-associated lipocalin (NGAL) levels in several malignancies.
We evaluated NGAL measured in plasma or urine as both prognostic and
diagnostic marker for different types of human tumors.
RESULTS:
We
included 35 studies dedicated to colorectal, pancreas, breast, thyroid,
gastric, kidney, endometrial, brain, liver, lung, esophageal, oral and
ovarian cancers......
CONCLUSIONS:
NGAL
determination in plasma and urine could be useful in the prognosis of
colorectal and breast cancer, but its prognostic accuracy remains
uncertain for other human tumors.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.